Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05104047 · ClinicalTrials.gov registry record · NA
Distal Peripheral Neuropathy in Type 2 Diabetes
A NA study of Diabetes and Peripheral Neuropathy, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 2
- Study locations
NCT05104047 is a NA study of Diabetes and Peripheral Neuropathy that has completed, run by New York University. The registered enrollment target is 44 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05104047, a NA study of Diabetes and Peripheral Neuropathy, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 2
- Study locations
Study Summary
Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with Type 2 diabetes. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. This is a preliminary study at assessing the feasibility, efficiency and preliminary efficacy of a novel non-pharmacologic pain management approach, moxibustion, to reduce DSP pain and improve quality of life.
Conditions Studied
Interventions
- OTHER Moxibustion - Traditional (Active)
- OTHER Moxibustion - Smokeless - (Active)
- OTHER Placebo Moxibustion
Study Locations (2)
New York
- New York University, Division of Special Studies in Symptom Management - New York
- NYU Special Studies in Symptom Management - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2019-07-29 |
| Est. Completion | 2022-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05104047
The ClinicalTrials.gov registry entry for NCT05104047 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (99% lower). The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Moxibustion - Traditional (Active) is the first listed.
NCT05104047 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05104047 about?
NCT05104047 is a clinical study titled "Distal Peripheral Neuropathy in Type 2 Diabetes". Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with Type 2 diabetes. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffectiv...
What is the current status of trial NCT05104047?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2019-07-29. Estimated completion is 2022-08-30.
What conditions does trial NCT05104047 study?
This clinical trial studies the following conditions: Diabetes, Peripheral Neuropathy, Pain, Neuropathic.
What interventions are being tested in trial NCT05104047?
The interventions under investigation include: Moxibustion - Traditional (Active) (OTHER), Moxibustion - Smokeless - (Active) (OTHER), Placebo Moxibustion (OTHER).
Who is sponsoring clinical trial NCT05104047?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05104047 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.